Biogen Beefs Up Immuno Pipeline with Potential $1.8B HI-Bio Acquisition
Pictured: Biogen's headquarters in Cambridge, Massachusetts/iStock, hapabapa Biogen announced on Wednesday that it is expanding its presence in the immunology space through a potential $1.8 billion deal to buy privately held biotech Human …